Daily Sepsis Research Analysis
Analyzed 43 papers and selected 3 impactful papers.
Summary
Three papers advance sepsis science across immunology, phenotyping, and public health. A multi-omics/mechanistic study implicates PCED1B-expressing naive CD4+ T cells as protective and potentially causal in sepsis outcomes; a deep temporal graph model defines organ-interaction-based sepsis phenotypes with external validation and early predictability; and a national pediatric melioidosis analysis maps high-risk trajectories and system-level needs.
Research Themes
- Immune cell-mediated protection and causal inference in sepsis
- Dynamic organ interaction-based sepsis subphenotyping and early prediction
- Epidemiology of pediatric melioidosis and system-level sepsis care planning
Selected Articles
1. Protective role of PCED1B-expressing naive CD4+ T cells in sepsis.
Integrated scRNA-seq, bulk RNA-seq, and Mendelian randomization implicate PCED1B-expressing naive CD4+ T cells as causally protective in sepsis, with lower 28-day mortality linked to higher naive CD4+ T cell proportions. Mechanistically, PCED1B+ CD4+ T cells interface with monocytes/dendritic cells and B cells via MIF–CD74 signaling axes, suggesting immunometabolic modulation.
Impact: This study combines causal inference with mechanistic validation, elevating a T-cell subset (PCED1B+ naive CD4+ T cells) from association to plausible causal relevance in sepsis outcomes, and proposes actionable immunotherapy targets.
Clinical Implications: PCED1B expression and naive CD4+ T cell proportion may serve as prognostic biomarkers and guide immunomodulatory strategies. Clinical trials could test therapies that preserve or augment naive CD4+ T cell pools or modulate the MIF–CD74 axis.
Key Findings
- Naive CD4+ T cells are significantly depleted in sepsis; 33 hub genes identified by scRNA-seq.
- Higher naive CD4+ T cell proportion associates with reduced sepsis occurrence (OR 0.90) and 28-day mortality (OR 0.75) in MR analyses.
- PCED1B shows a strong causal link to 28-day mortality (OR 0.64) and mediates the naive CD4+ T cell proportion effect.
- PCED1B+ CD4+ T cells likely signal via MIF–(CD74+CD44) and MIF–(CD74+CXCR4) axes with myeloid and B-lineage cells.
Methodological Strengths
- Integrative design combining scRNA-seq, bulk RNA-seq, Mendelian randomization/MR-BMA, and experimental validation.
- Consistent findings across human datasets, clinical samples, and mouse models.
Limitations
- Causal inference relies on validity of genetic instruments and assumptions of MR.
- Heterogeneity of public datasets and lack of prospective interventional validation.
Future Directions: Prospective validation of PCED1B as a prognostic/therapeutic biomarker; interventional studies targeting naive CD4+ T cell maintenance or MIF–CD74 pathways; development of clinically deployable assays.
BACKGROUND: Sepsis is a global health challenge associated with high morbidity and mortality rates. Early diagnosis and treatment are challenging because of the limited understanding of its underlying mechanisms. This study aimed to identify effective biomarkers for diagnosing and treating sepsis through an integrated multi-method approach. METHODS: Publicly available single-cell RNA sequencing (scRNA-seq) and bulk RNA-seq datasets were analyzed for naive CD4+ T cell-specific genes. Based on these hub genes, Mendelian randomization (MR) analysis, followed by the MR-Bayesian model averaging (MR-BMA) algorithm, was implemented to explore the causality between these genes and sepsis. In addition, single-cell-type expression analysis, cell-cell communication detection, metabonomic evaluation, clinical samples, and both in vivo and in vitro studies were conducted to unveil the underlying mechanisms of potential therapeutic targets. RESULTS: scRNA-seq revealed significant depletion of naive CD4+ T cells in sepsis, identifying 33 key genes. Both MR and MR-BMA analyses confirmed that elevated proportion of naive CD4+ T cell in total CD4+ T cells (naive CD4+ T cell % CD4+ T cell) were related to sepsis occurrence (odds ratio [OR] = 0.90, 95% confidence interval [CI], 0.83-0.97, P = 0.007) and 28-day mortality associated with sepsis (OR = 0.75, 95% CI, 0.64-0.88, P <0.001). Notably, among the 33 hub genes, PC-esterase domain containing 1B (PCED1B) exhibited a strong causal association with 28-day mortality in patients with sepsis (OR = 0.64, 95% CI, 0.51-0.81, P <0.001), which was further validated by bulk RNA-seq analysis. PCED1B mediated the impact of proportion of naive CD4+ T cell in CD4+ T cell on sepsis-related mortality. In addition, clinical samples and both in vivo and in vitro experiments validated the elevated expression of PCED1B in naive CD4+ T cells derived from sepsis patients and mice. Mechanistic investigations revealed PCED1B+ CD4+ T cells may interact with monocytes/dendritic cells through the MIF-(CD74+CD44) axis, concurrently engaging with B cells/plasmablasts through the MIF-(CD74+CXCR4) axis, thereby regulating multiple metabolic alterations in sepsis. CONCLUSION: The interplay between PCED1B and naive CD4+ T cells, as revealed by this study, is instrumental in developing immunotherapeutic strategies for sepsis.
2. Subphenotyping sepsis based on organ interaction trajectory using a deep temporal graph clustering model: a retrospective cohort study.
A deep temporal graph model quantified 48-hour organ interaction trajectories, defining three sepsis phenotypes with distinct coupling patterns and mortality (5.6% vs 38.3%). An early classifier predicted phenotypes at 4 hours (AUROC 0.84), and exploratory analyses suggested phenotype-specific differences in fluid strategy benefits.
Impact: This introduces a reproducible, externally validated approach to dynamic sepsis subphenotyping based on organ coupling, enabling early identification and hypothesis generation for tailored resuscitation.
Clinical Implications: If prospectively validated, early phenotype assignment could guide fluid targets and resource allocation (e.g., ICU intensity) and stratify patients in clinical trials to improve treatment effect detection.
Key Findings
- Three phenotypes (A–C) with distinct organ coupling trajectories and mortality were identified across 10,181 (derivation) and 6208 (external validation) patients.
- An early classifier predicted phenotypes at 4 hours post-diagnosis with AUROC 0.84 (95% CI 0.83–0.86).
- Exploratory, propensity-adjusted analyses suggested phenotype-specific differences in beneficial fluid ranges.
- External validation demonstrated robust clustering performance, supporting generalizability.
Methodological Strengths
- Large multi-cohort design with external validation and benchmarking versus state-of-the-art clustering algorithms.
- Early prediction (4 h) using a simplified classifier and exploratory causal adjustment for fluid strategies.
Limitations
- Retrospective observational design with potential residual confounding and dataset-era effects (MIMIC-III).
- Fluid strategy findings are exploratory and require prospective interventional validation.
Future Directions: Prospective trials testing phenotype-guided resuscitation; integration into EHR for real-time decision support; biological studies linking organ coupling patterns to molecular pathways.
BACKGROUND: Sepsis is a heterogeneous syndrome with varying degrees of multi-organ dysfunction. Identifying dynamic inter-organ interactions is critical for accurate sepsis subphenotyping and targeted therapy, yet remains unexplored. In this study, we aimed to quantify the dynamic trajectories of organ interactions to define sepsis phenotypes, supporting personalized treatment and clinical decision-making. METHODS: We proposed a novel deep temporal graph clustering model to identify sepsis phenotypes by quantifying dynamic multi-organ interactions within 48 h post-diagnosis. The model was trained and validated on the Medical Information Mart for Intensive Care III (MIMIC-III) dataset (admissions from 2001 to 2012) and externally validated on the eICU Collaborative Research (eICU) dataset (admissions from 2014 to 2015). Its effectiveness was benchmarked against state-of-the-art clustering algorithms. Patient characteristics, multi-organ system states coupling patterns, and prognostic outcomes were compared across the identified phenotypes. Extreme gradient boosting (XGBoost) was used for early phenotype classification at 4 h post-diagnosis. To enhance clinical applicability, a user-friendly web interface was developed. Propensity score matching and weighted logistic regression were employed to evaluate the effects of the fluid management strategies on in-hospital mortality of patients with various phenotypes. FINDINGS: A total of 10,181 and 6208 unique sepsis patients were employed as the cohorts for the model development and external validation, respectively. Three distinct phenotypes were identified and labeled as Phenotype A, B, and C, exhibiting significant differences in baseline characteristics, organ system states coupling patterns, and outcomes (P-value < 0.05). Phenotype A had the lowest mortality (5.59%) and accounted for the largest proportion of patients (46.34%). In contrast, Phenotype C represented the highest mortality (38.27%) and comprised the smallest proportion (22.78%). Phenotype A was characterized by sustained synchronous improvement across organ system states. Phenotype B showed persistent decoupling of organ system states. Phenotype C exhibited a rapid transition from early asynchrony to synchronization. The model demonstrated robust clustering performance in external validation. The simplified classifier showed high predictive performance, achieving an area under the receiver operating characteristic curve (AUROC) of 0.84 (95% CI [0.83, 0.86]) for phenotype prediction at 4 h post-diagnosis. The beneficial fluid management strategies varied across different phenotypes, highlighting the need for targeted fluid intervals. INTERPRETATION: This study characterizes sepsis phenotypes using organ interaction trajectories and identifies three heterogeneous patterns of disease progression. These patterns offer new insights into the underlying pathophysiological mechanisms of sepsis, which can support the design of clinical trials on disease progression and guide the optimal allocation of intensive care resources. FUNDING: This study was funded by the National Nature Science Foundation of China (No. 32371372) and the National Key Research and Development Program of China (No. 2022YFC2009503).
3. Mortality among hospitalized children with melioidosis in Thailand: a retrospective national database analysis (2015-2023).
A nationwide Thai analysis of 5044 pediatric melioidosis admissions found 1.7% mortality, with high-risk progression from pneumonia to acute respiratory failure, shock, and DIC. The burden concentrates in the Northeast, supporting targeted sepsis bundles, early melioidosis-active therapy, and seasonal PICU surge/transfer protocols.
Impact: Defines national pediatric sepsis trajectories for an endemic pathogen using real-world data, directly informing equitable critical-care planning and timely antimicrobial coverage.
Clinical Implications: Embed pediatric sepsis bundles with melioidosis-active empiric therapy in endemic seasons/regions, enhance early recognition of pneumonia-to-shock trajectories, and prepare PICU surge capacity and transfer protocols.
Key Findings
- Among 5044 pediatric admissions, overall mortality was 1.7%, with deaths concentrated in tertiary hospitals (71.4%).
- Common foci and complications included lower respiratory tract infection (17.6%), septic shock (2.9%), acute respiratory failure (3.2%), acute renal failure (2.3%), and DIC (1.7%).
- Incidence peaked in 2023 and was geographically concentrated in the Northeast (80.5% of cases).
- Mortality was significantly higher with septic shock and acute respiratory failure compared to those without these complications.
Methodological Strengths
- National coverage over nine years with large sample size enabling robust epidemiologic estimates.
- Clear mapping of complication trajectories relevant to sepsis care pathways.
Limitations
- Administrative coding may misclassify diagnoses; limited granularity on microbiology and treatment timing.
- Retrospective design precludes causal inference; potential unmeasured confounding.
Future Directions: Prospective registries linking microbiology, timing of antibiotics, and outcomes; evaluation of bundled care with melioidosis-active empirics; modeling seasonal PICU surge needs.
BACKGROUND: Pediatric melioidosis remains under-characterized nationally in Thailand, hindering triage and critical-care planning. We quantified epidemiology, complications, and mortality correlates among hospitalized children. METHODS: Retrospective analysis of Thailand's National Health Security Office database from January 2015 to Dec 2023, including patients <18 years with principal melioidosis. Incidence and case-fatality rate were calculated. Mortality-related clinical characteristics were compared using descriptive statistics. FINDINGS: Among 5044 admissions, 58.3% were male and 80.5% from the Northeast; annual incidence ranged 3.7-5.8 per 100,000, peaking in 2023. Median length of hospital stay was 11 days. Lower respiratory tract infection was the commonest localized focus (17.6%), followed by septic shock (2.9%). Organ dysfunction consisted of acute respiratory failure 3.2%, acute renal failure 2.3%, and disseminated intravascular coagulation (DIC) 1.7%. There were 2.3% required intubation with mechanical ventilation >96 h, and 2.2% needed renal replacement therapy. Overall, 84 children died (1.7%); deaths clustered in tertiary hospitals (71.4%). Mortality was markedly higher among children with septic shock, lower respiratory tract infection, and acute respiratory failure compared with children without these complications. INTERPRETATION: National data identify a Northeast-weighted pediatric burden and a high-risk trajectory from pneumonia to acute respiratory failure, shock, and DIC. Embedding pediatric sepsis bundles with early melioidosis-active therapy and seasonal pediatric intensive care unit (PICU) surge/transfer protocols, may shorten time-to-treatment and reduce deaths substantially and equitably. FUNDING: This study was supported by the Fundamental Fund, Khon Kaen University, Thailand.